<table className="table">
  <caption>
    <p>
      Treatment Strategies for Urinary Incontinence
    </p>
  </caption>
  <thead>
    <tr>
      <th colSpan="1" rowSpan="1">
        <p>
          Incontinence Type
        </p>
      </th>
      <th colSpan="1" rowSpan="1">
        <p>
          Behavioral Therapy
        </p>
      </th>
      <th colSpan="1" rowSpan="1">
        <p>
          Pharmacologic Therapy
        </p>
      </th>
      <th colSpan="1" rowSpan="1">
        <p>
          Other Therapies
        </p>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr className="group_1-1 row-odd">
      <td colSpan="1" rowSpan="1">
        <p>
          Stress
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Pelvic floor muscle training (Kegel exercises) with or without biofeedback
        </p>
        <p>
          Instruct patient to contract the pelvic floor as if attempting to avoid urination and sustain the contraction for 10 seconds. Contractions should be performed in three or four sets of 10 each day.
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Topical vaginal estrogen (postmenopausal women)
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Pessaries, injectable bulking agents, sling cystourethropexy
        </p>
      </td>
    </tr>
    <tr className="group_1-2 row-even">
      <td colSpan="1" rowSpan="1">
        <p>
          Urge (overactive bladder with incontinence)
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Bladder training/timed voiding
        </p>
        <p>
          Instruct patient to schedule voiding attempts at intervals shorter than the usual time between incontinence episodes, regardless of the urge to void, gradually increasing the time between voids.
        </p>
        <p>
          If urgency occurs before the designated voiding time, instruct patients to use pelvic floor muscle contraction until the urge passes and then proceed with voiding directly afterward.
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Anticholinergic/antimuscarinics (oxybutynin, darifenacin, solifenacin, tolterodine, fesoterodine, trospium)
        </p>
        <p>
          β-Adrenergics (mirabegron, vibegron)
        </p>
        <p>
          Topical vaginal estrogen (postmenopausal women)
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Spinal neuromodulators, botulinum toxin injections
        </p>
      </td>
    </tr>
    <tr className="group_1-3 row-odd">
      <td colSpan="1" rowSpan="1">
        <p>
          Overflow
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Double voiding
        </p>
        <p>
          Instruct patient to remain relaxed at the toilet for a minute after voiding and then attempt to void again.
        </p>
        <p>
          Triggered voiding
        </p>
        <p>
          Instruct patient to stimulate voiding and encourage complete emptying by leaning forward, squeezing the pelvic floor at the end of urination to promote emptying; also massaging the umbilicus, suprapubic area, and tapping the bladder.
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          α-Blockers (alfuzosin, doxazosin, prazosin, terazosin, silodosin, tamsulosin)
        </p>
        <p>
          5α-Reductase inhibitors (dutasteride and finasteride) for BPH-related symptoms
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Transurethral prostatectomy can be considered for BPH-related symptoms
        </p>
        <p>
          Scheduled intermittent catheterization
        </p>
      </td>
    </tr>
    <tr className="group_1-4 row-even">
      <td colSpan="1" rowSpan="1">
        <p>
          Functional
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Caregiver-prompted timed voiding
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          No recommended pharmacologic therapies
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          None routinely recommended
        </p>
      </td>
    </tr>
    <tr className="group_1-5 row-odd">
      <td colSpan="1" rowSpan="1">
        <p>
          Mixed
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Pelvic floor muscle training with or without biofeedback
        </p>
        <p>
          Bladder training/timed voiding
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Consider antimuscarinics or β-adrenergics
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Consider therapies for stress or urge incontinence depending on predominant symptoms
        </p>
      </td>
    </tr>
  </tbody>
</table>
